Portola Pharmaceuticals Inc. buy marge
Start price
21.06.15
/
50%
€39.41
Target price
22.07.15
€45.00
Performance (%)
18.34%
End price
22.07.15
€46.63
Summary
This prediction ended on 22.07.15 with a price of €46.63. The prediction had a final performance of 18.34%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
| iShares Core DAX® | 1.080% | -2.131% | 14.264% | 15.290% |
| iShares Nasdaq 100 | 0.362% | 7.059% | 35.383% | 56.103% |
| iShares Nikkei 225® | -1.155% | -0.483% | 8.258% | 4.324% |
| iShares S&P 500 | 0.806% | 5.037% | 29.635% | 49.529% |
Comments by marge for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
Portola Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Vom Mitglied beendet)
Stopped prediction by marge for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.69
01.01.19
01.01.19
€19.00
06.07.20
06.07.20
-4.09%
06.07.20
06.07.20
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49.88
28.06.17
28.06.17
€54.12
20.12.18
20.12.18
-70.04%
20.12.18
20.12.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€48.25
23.07.15
23.07.15
€54.12
18.07.16
18.07.16
-57.92%
18.07.16
18.07.16